Telemedicine, the use of electronic communication for the delivery of remote clinical care, has been recognized as a critical strategy during the ongoing COVID-19 pandemic to limit the risk of person-to-person transmission of the virus as social distancing became the norm.
It was widely anticipated that COVID-19 may be the tipping point for telemedicine as the full potential of the technology was increasingly realized by patients, healthcare systems, and payers. As a result of the pandemic, regulations and policies governing reimbursement and use of telemedicine have changed significantly, leading to expanded access and an unprecedented demand for these services. Nevertheless, following a substantial surge in usage since early 2020, the demand for telemedicine is starting to level off.
In this report, the analyst assesses the telemedicine uptake in the US, Japan, the 4EU (France, Italy, Germany and Spain), and the United Kingdom (UK) and examines the healthcare provider’s perspective on combining in-person consultations with telemedicine.
This report combines information obtained from secondary sources and primary research with healthcare industry professionals, key opinion leaders (KOLs), and physicians from different therapy areas (pediatrics, pulmonology, primary case, dermatology, internal medicine, endocrinology, cardiology, and infectious disease). The interviews and surveys with physicians and KOLs were conducted between 2020-2021. Components of the report include:
It was widely anticipated that COVID-19 may be the tipping point for telemedicine as the full potential of the technology was increasingly realized by patients, healthcare systems, and payers. As a result of the pandemic, regulations and policies governing reimbursement and use of telemedicine have changed significantly, leading to expanded access and an unprecedented demand for these services. Nevertheless, following a substantial surge in usage since early 2020, the demand for telemedicine is starting to level off.
In this report, the analyst assesses the telemedicine uptake in the US, Japan, the 4EU (France, Italy, Germany and Spain), and the United Kingdom (UK) and examines the healthcare provider’s perspective on combining in-person consultations with telemedicine.
Scope
This report combines information obtained from secondary sources and primary research with healthcare industry professionals, key opinion leaders (KOLs), and physicians from different therapy areas (pediatrics, pulmonology, primary case, dermatology, internal medicine, endocrinology, cardiology, and infectious disease). The interviews and surveys with physicians and KOLs were conducted between 2020-2021. Components of the report include:
- Telemedicine Overview - an overview of telemedicine, including benefits and barriers.
- Telemedicine Sector in the US, Europe, and Japan Before COVID-19 - A review of the telemedicine sector in the US, Europe, and Japan before the pandemic, including online survey and poll data.
- Telemedicine Sector in the US, Europe, and Japan During COVID-19 - A review of the telemedicine sector growth in the US, Europe, and Japan during the pandemic, including online survey and poll data.
- Telemedicine Sector in the US, Europe, and Japan After COVID-19 - A review of the telemedicine sector post COVID-19, including online survey and poll data.
Reasons to Buy
- Get an overview on how telemedicine is being used today and how the technology is expected to affect the healthcare sector in the future.
- Explore the changing telemedicine regulatory landscapes in the US, Europe, and Japan.
- See how physician use of telemedicine has changed in these regions as a result of the pandemic.
- Explore how physician use of telemedicine is expected to change in the future in these regions.
Table of Contents
1 Table of Contents1.1 Study Design
1.1.1 Survey Respondent Mix
1.1.2 Objectives and Design
1.1.3 Survey Respondent Profiles
1.2 Key Findings
1.3 Telemedicine Overview
1.3.1 What Is Telemedicine?
1.3.2 COVID-19 Accelerated the Use of Remote Monitoring Technologies
1.3.3 What Are the Different Types of Telemedicine?
1.3.4 What Are the Benefits of Telemedicine?
1.3.5 What Are the Common Barriers to Telemedicine?
1.3.6 Companies Playing an Active Role in the Telemedicine Field
1.4 Telemedicine Sector in the US, Europe, and Japan Before COVID-19
1.4.1 In the US, Pre-Pandemic Use of Telemedicine Was Rising but Remained Low Overall
1.4.2 In Europe, the UK was among the Most Established Markets for Telemedicine Before COVID-19
1.4.3 Use of Telemedicine Was Still at the Infancy Stage in Japan
1.4.4 Telemedicine Sector Before COVID-19 - Survey Data
1.4.5 Telemedicine Sector Before COVID-19 - Survey Data by Region
1.4.6 Telemedicine Use Before COVID-19 - Physicians Perspective
1.5 Telemedicine Sector in the US, Europe, and Japan During COVID-19
1.5.1 Social Distancing and Lockdown Measures Have Led to a Surge in Telemedicine Use
1.5.2 The Regulatory Landscape for Telemedicine in the US Has Changed Significantly as a Result of the Pandemic
1.5.3 Changes to Reimbursement Policies in Some European Countries Have Led to a Surge in Demand for Telemedicine
1.5.4 Japan Has Introduced New Measures to Ease Telemedicine Restrictions
1.5.5 Telemedicine Sector During COVID-19 - Survey Data
1.5.6 Telemedicine Sector During COVID-19 - Survey Data by Region
1.5.7 Increased Website Traffic for Leading Provider Telemedicine Platforms from March 2020
1.5.8 Job Analytics - Telemedicine-Related Job Growth in the US
1.5.9 Use of Telemedicine in Clinical Trials
1.5.10 Telemedicine Use During COVID-19 - Physicians Perspective
1.6 Telemedicine Sector Post-COVID-19
1.6.1 Telemedicine - Industry Trends Accelerated the Most by COVID-19
1.6.2 The Future of Telemedicine Post-COVID-19
1.6.3 Telemedicine Sector Post-COVID-19 - Survey Data
1.6.4 Telemedicine to Reach its Peak
1.6.5 Telemedicine Use After COVID-19 - Physicians Perspective
1.7 Summary of Key Findings
1.8 Appendix
1.9 Contact Us
